Seeking new leader, EMA taps interim head; Sanofi ($SNY) sells U.K. site to Covance;

@FiercePharma: Watson nabs authorized-generic deal with J&J. Article | Follow @FiercePharma

> The European Medicines Agency has appointed its administrative head, Andreas Pott, as acting executive director from Jan. 1, following a series of delays in recruiting a new permanent leader. Report

> The Sanofi-Aventis site at Alnwick, U.K., has been bought by American firm Covance, with the majority of the 140 staff transferring to the new owner. Article

> At a time when the FDA is increasingly criticized for its oversight of foreign drug-making plants, the chief of its recently created International Compliance Branch has departed. Item

> Valeant Pharmaceuticals (VRX.TO) posted a quarterly loss, hurt by increased expenses, in its first quarter after being bought by Biovail and set a special dividend as well as a $1.5 billion buyback. Report

> Amylin Pharmaceuticals (AMLN) Chief Executive Daniel Bradbury said the drugmaker can withstand the recent setback it suffered when U.S. regulators declined to approve its proposed diabetes drug Bydureon. News

> Watson Pharmaceuticals (WPI.N) posted a huge drop in net income due to a legal settlement charge but reported profit excluding items and revenue slightly ahead of Wall Street targets. Story

> Par Pharmaceutical (PRX.N) posted a better-than-expected quarterly profit, helped by robust sequential growth of its generic drugs and a strong start to its omeprazole sodium bicarbonate capsules. Article

 @FierceBiotech: Biogen restructuring claims 650 jobs. Article | Follow @FierceBiotech

> Report: Acceleron cuts 40% of staff. Story

> NASDAQ gives Cell Therapeutics another warning. Item

> Newron, Merck Parkinson's drug misses goal. Article 

> CRO Charles River cuts 300 more jobs. Item 

Vaccines News

> Study: Support of mandatory HPV vaccine declines after negative news coverage. Item 

> GlobeImmune HCV vax shows promise in trial. Story 

> Sanofi dengue vax enters PhIII. Article 

> The 26 vaccine-preventable diseases. Report 

> Report: Higher income parents increasingly forgoing kids' vaccinations. News

Manufacturing News

> Safety advocates say FDA guidance not enough. Article

> DARPA efforts tweak tobacco-based vax making. Story 

> ERP provides ops boosts at AHN, BioVectra. Item 

> Plastic pallet makers report for duty. Article 

> Novartis journeys to Mecca for Saudi vax effort. Report

> FDA reminds, guides on fighting musty odor. Item

And finally ... A drug approved to help staunch bleeding in people with hemophilia raises the risk of heart attacks and stroke when it's used to stop life-threatening bleeding due to other conditions, such as trauma or surgery, a new study finds. Report

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.